Pages with the fewest revisions
Jump to navigation
Jump to search
Showing below up to 500 results in range #101 to #600.
- ATP6V1C2 (1 revision)
- ARIH1 (1 revision)
- 13q deletion syndrome (1 revision)
- ATC code A (1 revision)
- ASXL1 (1 revision)
- ASPECT (1 revision)
- ACADL (1 revision)
- ADK (gene) (1 revision)
- 16S ribosomal RNA (1 revision)
- ABI1 (1 revision)
- ATP11C (1 revision)
- ABTB1 (1 revision)
- ATP11B (1 revision)
- ATP-dependent DNA helicase 2 subunit 2 (1 revision)
- 9q34 deletion syndrome (1 revision)
- ASCC3 (1 revision)
- Aasfdhfuda (1 revision)
- ATPIF1 (1 revision)
- ANP32D (1 revision)
- ADCK3 (1 revision)
- AVNRT diagnostic study of choice (1 revision)
- ABCC2 (1 revision)
- ACC/AHA guidelines for dextro-transposition of great arteries (1 revision)
- AVPI1 (1 revision)
- ALDH1B1 (1 revision)
- AAA1 (1 revision)
- ACSL6 (1 revision)
- AA battery (1 revision)
- ANCA-associated vasculitides (1 revision)
- AD-mix (1 revision)
- A-box 1 of insulin gene (1 revision)
- APOBEC4 (1 revision)
- ABCC4 (1 revision)
- 60S ribosomal protein L30 (1 revision)
- ABCA9 (1 revision)
- ALX1 (1 revision)
- ABCB8 (1 revision)
- ABHD11 (1 revision)
- ADAM8 (1 revision)
- ADAM17 (1 revision)
- AP4E1 (1 revision)
- AM-919 (1 revision)
- ANKRD25 (1 revision)
- 17-beta-hydroxysteroid dehydrogenase deficiency x ray (1 revision)
- ARF1 (1 revision)
- AADACL4 (1 revision)
- ACVR1B (1 revision)
- AICDA (1 revision)
- ABCA10 (1 revision)
- ANKHD1 (1 revision)
- 60S ribosomal protein L35a (1 revision)
- AAK (1 revision)
- AASDHPPT (1 revision)
- ABCB11 (1 revision)
- ACTL8 (1 revision)
- AKR1A1 (1 revision)
- ACACA (1 revision)
- AO/OTA classification for the distal tibial Fracture (1 revision)
- ATXN10 (1 revision)
- 7-Dehydrocholesterol reductase (1 revision)
- 60S ribosomal protein L37a (1 revision)
- ARS2 (1 revision)
- ABCA13 (1 revision)
- ACOT4 (1 revision)
- AGPAT5 (1 revision)
- ANKRD15 (1 revision)
- ABT-239 (1 revision)
- APBA3 (1 revision)
- 18-Methoxycoronaridine (1 revision)
- 18S ribosomal RNA (1 revision)
- APBB2 (1 revision)
- 1993 Clinton health care plan (1 revision)
- 1998 Klang Valley water crisis (1 revision)
- 1 E-10 m (1 revision)
- 1 E-11 m (1 revision)
- 1 E7 s (1 revision)
- 1p36 deletion syndrome (1 revision)
- APTX 4869 (1 revision)
- 2,2,2-Trichloroethanol (1 revision)
- 2,2,4-Trimethylpentane (1 revision)
- 2,3,4,5-Tetramethoxyamphetamine (1 revision)
- 2,3-Bisphosphoglycerate (1 revision)
- 2,3-Dihydropyran (1 revision)
- 2,3-Dihydroxy-3-methylpentanoic acid (1 revision)
- 2,3-squalene oxide (1 revision)
- 2,4,5-Trichlorophenoxyacetic acid (1 revision)
- ADAMTS2 (1 revision)
- ARMC5 (1 revision)
- 2,4-Dichlorophenol (1 revision)
- 2,4-Dinitrophenol (1 revision)
- ARHGEF9 (1 revision)
- ARNT2 (1 revision)
- ADAMTSL1 (1 revision)
- 2,4 Dienoyl-CoA reductase deficiency (1 revision)
- ARMC9 (1 revision)
- 2,5-Dimethoxy-4-ethylamphetamine (1 revision)
- 2,5-Dimethoxy-4-iodoamphetamine (1 revision)
- AVNRT screening (1 revision)
- 2,5-Dimethoxy-4-nitroamphetamine (1 revision)
- 2,5-Dimethoxyphenethylamine (1 revision)
- 2,5-Dimethylfuran (1 revision)
- ACP1 (1 revision)
- ASB1 (1 revision)
- ASB3 (1 revision)
- AATK (1 revision)
- 2-Acetylaminofluorene (1 revision)
- 2-Aminoethoxydiphenyl borate (1 revision)
- 2-Aminomuconic acid (1 revision)
- ASIC3 (1 revision)
- ACOT7 (1 revision)
- ASH2L (1 revision)
- ASTL (1 revision)
- 2-Bromopropane (1 revision)
- 2-Butyl-3-(p-tolyl)quinuclidine (1 revision)
- 2-Chlorophenol (1 revision)
- 2-Ethylhexanol (1 revision)
- ATC code H01 (1 revision)
- 2-Hydroxyglutaricaciduria (1 revision)
- 2-Iodoxybenzoic acid (1 revision)
- 2-Isopropyl-5-methyl-1-(2,6-dihydroxy-4-nonylphenyl)cyclohex-1-ene (1 revision)
- 2-Me-DET (1 revision)
- 2-Methyl-2-nitrosopropane (1 revision)
- 2-Methyl-3,3-diphenyl-3-propanolamine (1 revision)
- 2-Methyl-4-Chlorophenoxyacetic Acid (1 revision)
- 2-Methylbutyryl-CoA (1 revision)
- 2-Methylbutyryl-CoA dehydrogenase deficiency (1 revision)
- 2-Nitropropane (1 revision)
- 2-Nonenal (1 revision)
- ATP-binding cassette transporter (1 revision)
- 2-Phenylphenol (1 revision)
- 2-Pyridone (1 revision)
- 2-Pyrone (1 revision)
- 2-chloroethanol (1 revision)
- 2-hydroxyphytanoyl-CoA lyase (1 revision)
- ATP5SL (1 revision)
- 2-propanoyl-3-(4-isopropylphenyl)-tropane (1 revision)
- ATP6V1E2 (1 revision)
- ATP synthase, H+ transporting, mitochondrial F1 complex, alpha 1 (1 revision)
- ATPAF1 (1 revision)
- 2007 WikiDoc Foundation Scholars (1 revision)
- ANXA4 (1 revision)
- AMP deaminase (1 revision)
- AEBP2 (1 revision)
- AUP1 (1 revision)
- 2018 ACC/AHA/HRS Guideline on the Evaluation and Management of Patients With Bradycardia and Cardiac Conduction Delay (1 revision)
- ARIH2 (1 revision)
- ATXN2 (1 revision)
- 21-Hydroxylase Deficiency (patient information) (1 revision)
- AZI1 (1 revision)
- AXIN1 (1 revision)
- ACRRM (1 revision)
- AFF3 (1 revision)
- A Review Of Loan Modification (1 revision)
- Abacavir lamivudine adverse reactions (1 revision)
- AGBL4 (1 revision)
- AGXT2 (1 revision)
- AIG1 (1 revision)
- AIF1 (1 revision)
- ACSBG2 (1 revision)
- AKAP2 (1 revision)
- ALDH4A1 (1 revision)
- ACAT2 (1 revision)
- ALDH3A1 (1 revision)
- AKR7A3 (1 revision)
- AKR1C4 (1 revision)
- ACSM2B (1 revision)
- ACBD3 (1 revision)
- ALDH1L1 (1 revision)
- ACSS3 (1 revision)
- ALPPL2 (1 revision)
- ALDH3B2 (1 revision)
- ACER1 (1 revision)
- ALDOC (1 revision)
- ACCN2 (1 revision)
- ACTL6B (1 revision)
- ALPHA (psychedelic) (1 revision)
- 60S ribosomal protein L8 (1 revision)
- 60S ribosomal protein L37 (1 revision)
- ABI gene family member 3 (1 revision)
- ARHGEF3 (1 revision)
- AP2M1 (1 revision)
- 60S ribosomal protein L36a (1 revision)
- ALS Therapy Development Institute (1 revision)
- ANKRD26 (1 revision)
- 60S ribosomal protein L41 (1 revision)
- 60S ribosomal protein L39 (1 revision)
- AMOTL2 (1 revision)
- 7-Amino-actinomycin D (1 revision)
- 60S ribosomal protein L29 (1 revision)
- 60S ribosomal protein L4 (1 revision)
- A1CF (1 revision)
- AIR synthetase (FGAM cyclase) (1 revision)
- ACYP1 (1 revision)
- 60S ribosomal protein L32 (1 revision)
- 60S ribosomal protein L5 (1 revision)
- ADAM11 (1 revision)
- 8-Hyydroxyquinoline (1 revision)
- 60S ribosomal protein L7a (1 revision)
- ANXA11 (1 revision)
- 60S ribosomal protein L9 (1 revision)
- AD-36 (1 revision)
- ALDH3B1 (1 revision)
- ANKK1 (1 revision)
- 8-Aminoquinoline (1 revision)
- ACES (nutritional supplement) (1 revision)
- ACF (gene) (1 revision)
- 22q11.2 deletion syndrome case study one (1 revision)
- ACOT12 (1 revision)
- ANXA7 (1 revision)
- ABHD5 (1 revision)
- ANKRD17 (1 revision)
- AADAC (1 revision)
- AP4M1 (1 revision)
- 22q11.2 deletion syndrome echocardiography or ultrasound (1 revision)
- ACACB (1 revision)
- AAAS (gene) (1 revision)
- ANOVA-simultaneous component analysis (1 revision)
- 8-cell stage (1 revision)
- ACO1 (1 revision)
- AP1M1 (1 revision)
- AM-087 (1 revision)
- ABCC9 (1 revision)
- ADAM15 (1 revision)
- AP1GBP1 (1 revision)
- AADACL3 (1 revision)
- AMG-36 (1 revision)
- AM-4030 (1 revision)
- AOC2 (1 revision)
- ABRA (gene) (1 revision)
- ADAMTS12 (1 revision)
- ACOT1 (1 revision)
- ACOT11 (1 revision)
- AP4S1 (1 revision)
- 23andMe (1 revision)
- 24-Dehydrocholesterol reductase (1 revision)
- APBA2BP (1 revision)
- APA Task Force on Deceptive and Indirect Techniques of Persuasion and Control (1 revision)
- 2C-B (1 revision)
- 2C-B-BZP (1 revision)
- 2C-B-FLY (1 revision)
- APBB3 (1 revision)
- 2C-D (1 revision)
- APBB1IP (1 revision)
- APIP (1 revision)
- API oil-water separator (1 revision)
- APC (gene) (1 revision)
- 2C-I (1 revision)
- APOBEC3B (1 revision)
- APOBEC2 (1 revision)
- APOBEC3H (1 revision)
- APOBEC3D (1 revision)
- APOL1 (1 revision)
- APOLD1 (1 revision)
- APOL6 (1 revision)
- APOF (1 revision)
- APPL2 (1 revision)
- ARB Project (1 revision)
- AQP6 (1 revision)
- APPBP2 (1 revision)
- 2C-T-7 (1 revision)
- AREG (1 revision)
- ARD1A (1 revision)
- 2C-TFM (1 revision)
- ARHGAP44 (1 revision)
- 2R hypothesis (1 revision)
- 2b3a (1 revision)
- 2nd Skin (1 revision)
- ADAMTS17 (1 revision)
- 2α-(Propanoyl)-3β-(2-(6-methoxynaphthyl))-tropane (1 revision)
- 2β-propanoyl-3β-(2-naphthyl)-tropane (1 revision)
- 2β-propanoyl-3β-(4-tolyl)-tropane (1 revision)
- ARHGAP25 (1 revision)
- ARFGAP3 (1 revision)
- ARHGAP31 (1 revision)
- ARHGAP27 (1 revision)
- 3,4-Diaminopyridine (1 revision)
- 3,4-Dimethylamphetamine (1 revision)
- ARHGEF35 (1 revision)
- ADAMTS4 (1 revision)
- 3-Aminoisobutyric acid (1 revision)
- 3-Aminopyridine (1 revision)
- ARHGEF4 (1 revision)
- 3-Hydroxyacyl ACP dehydrase (1 revision)
- ARL15 (1 revision)
- ADCC (1 revision)
- 3-Methylcrotonyl-CoA carboxylase deficiency (1 revision)
- ARL6IP1 (1 revision)
- ADAMTS9 (1 revision)
- 3-Methylglutaconyl CoA (1 revision)
- ARMCX3 (1 revision)
- 3-Quinuclidinyl benzilate (1 revision)
- 3-Ureidopropionic acid (1 revision)
- 3-dehydrosphinganine reductase (1 revision)
- ARPC1A (1 revision)
- 3-hydroxy-3-methylglutaryl-CoA lyase deficiency (1 revision)
- ARREST (1 revision)
- ADCY10 (1 revision)
- 3-hydroxyacyl-coenzyme A dehydrogenase deficiency (1 revision)
- 3-hydroxyisobutyrate dehydrogenase (1 revision)
- ATC code M05 (1 revision)
- 3-methylglutaconic acid (1 revision)
- 310 helix (1 revision)
- ARUP Laboratories (1 revision)
- ASAH2B (1 revision)
- 3C-P (1 revision)
- ASA score (1 revision)
- 3T3-L1 (1 revision)
- ATRN (1 revision)
- 3 beta-hydroxysteroid dehydrogenase deficiency historical perspective (1 revision)
- 3 hydroxyisobutyric aciduria (1 revision)
- 3 methylcrotonic aciduria (1 revision)
- 3c syndrome (1 revision)
- 3m syndrome (1 revision)
- ASB6 (1 revision)
- 3β-(4'-chlorophenyl)-2β-(3'-phenylisoxazol-5'-yl)tropane (1 revision)
- ASCL2 (1 revision)
- 4,5-MDO-DMT (1 revision)
- 4,5-MDO-DiPT (1 revision)
- ADEPT (1 revision)
- ATC code H05 (1 revision)
- 4-Acetoxy-DET (1 revision)
- 4-Acetoxy-DIPT (1 revision)
- ASK-1 (1 revision)
- 4-Aminobiphenyl (1 revision)
- ADFP (1 revision)
- 4-Aminoquinoline (1 revision)
- 4-Androstene-3,6,17-trione (1 revision)
- AT-10 resin (1 revision)
- ACOT6 (1 revision)
- ATC code C10 (1 revision)
- 4-Chloroindole-3-acetic acid (1 revision)
- ATC code G03 (1 revision)
- 4-Dimethylaminophenol (1 revision)
- 4-HO-DBT (1 revision)
- 4-HO-DET (1 revision)
- 4-HO-DPT (1 revision)
- 4-HO-DiPT (1 revision)
- 4-HO-MET (1 revision)
- 4-HO-MPT (1 revision)
- 4-HO-pyr-T (1 revision)
- 4-Hydroxy-4-methylpentanoic acid (1 revision)
- ATC code L02 (1 revision)
- ATC code J (1 revision)
- 4-Hydroxytestosterone (1 revision)
- 4-MTA (1 revision)
- 4-MeO-MiPT (1 revision)
- 4-Methylbenzylidene camphor (1 revision)
- ATC code R07 (1 revision)
- 4-Methylthioamphetamine (1 revision)
- 4-Nitroaniline (1 revision)
- ATN1 (1 revision)
- 4-Oxalocrotonate tautomerase (1 revision)
- ADM2 (1 revision)
- AVID (1 revision)
- 40S (1 revision)
- ATP10A (1 revision)
- 40S ribosomal protein S11 (1 revision)
- 40S ribosomal protein S12 (1 revision)
- 40S ribosomal protein S13 (1 revision)
- 40S ribosomal protein S14 (1 revision)
- 40S ribosomal protein S15a (1 revision)
- ATOH8 (gene) (1 revision)
- 40S ribosomal protein S18 (1 revision)
- 40S ribosomal protein S19 (1 revision)
- ATXN7L2 (1 revision)
- ADP-specific glucokinase (1 revision)
- ADNP (gene) (1 revision)
- 40S ribosomal protein S23 (1 revision)
- 40S ribosomal protein S24 (1 revision)
- ATP5A1 (1 revision)
- 40S ribosomal protein S26 (1 revision)
- ATP9A (1 revision)
- 40S ribosomal protein S28 (1 revision)
- ADPRHL2 (1 revision)
- 40S ribosomal protein S3 (1 revision)
- ATPase, H+ transporting, lysosomal V0 subunit a1 (1 revision)
- 40S ribosomal protein S4, Y isoform 1 (1 revision)
- 40S ribosomal protein S4, Y isoform 2 (1 revision)
- 40S ribosomal protein S5 (1 revision)
- 40S ribosomal protein S7 (1 revision)
- 40S ribosomal protein S8 (1 revision)
- 40S ribosomal protein S9 (1 revision)
- 454 Life Sciences (1 revision)
- ART3 (1 revision)
- AVNRT case study one (1 revision)
- ATC code R03 (1 revision)
- ATPase ASNA1 (1 revision)
- ARL13A (1 revision)
- 5'-3' exoribonuclease 1 (1 revision)
- Abacavir lamivudine dosage and administration (1 revision)
- Ф29 phage (1 revision)
- 5'-Phosphoribosylformylglycinamidine (1 revision)
- 5'-phosphoribosyl-4-carboxy-5-aminoimidazole (1 revision)
- 5'-phosphoribosyl-5-aminoimidazole (1 revision)
- 5' flanking region (1 revision)
- 5,10-Methylenetetrahydrofolate (1 revision)
- 5,6-MDO-DMT (1 revision)
- 5,6-MDO-DiPT (1 revision)
- 5,6-MDO-MiPT (1 revision)
- 5,6-MeO-MiPT (1 revision)
- AZD2171 (1 revision)
- AV Conduction (1 revision)
- 5-Formamidoimidazole-4-carboxamide ribotide (1 revision)
- AZIN1 (1 revision)
- AFM (gene) (1 revision)
- Aaron's sign (1 revision)
- Aafact (1 revision)
- ATP synthase chain A (1 revision)
- ACAA1 (1 revision)
- AGMAT (1 revision)
- ALG12 (1 revision)
- ACSBG1 (1 revision)
- AGPAT9 (1 revision)
- AIDA interactive educational freeware diabetes simulator (1 revision)
- ACSF3 (1 revision)
- AIDSVAX (1 revision)
- AIP (gene) (1 revision)
- 5-HT receptor (1 revision)
- 5-Hydroxyindoleacetic acid (1 revision)
- 5-Hydroxytryptophan (1 revision)
- 5-Lipoxygenase activating protein (1 revision)
- AKAP (1 revision)
- 5-MeO-AET (1 revision)
- AKAP7 (1 revision)
- 5-MeO-DALT (1 revision)
- 5-MeO-DET (1 revision)
- 5-MeO-DMT (1 revision)
- 5-MeO-DPT (1 revision)
- 5-MeO-MiPT (1 revision)
- 5-MeO-NMT (1 revision)
- 5-MeO-pyr-T (1 revision)
- 5-MeS-DMT (1 revision)
- 5-Methoxy-diisopropyltryptamine (1 revision)
- 5-Methylcytosine (1 revision)
- 5-Methylindole (1 revision)
- 5-Methyltetrahydrofolate (1 revision)
- 5-Methyltetrahydrofolate-homocysteine methyltransferase (1 revision)
- AM-938 (1 revision)
- AM-411 (1 revision)
- ACS National Historical Chemical Landmarks (1 revision)
- 5-alpha-reductase deficiency case study one (1 revision)
- ACTION (1 revision)
- AARS2 (1 revision)
- 5-alpha-reductase deficiency cost-effectiveness of therapy (1 revision)
- ACTIVE A Trial (1 revision)
- 5-alpha-reductase deficiency electrocardiogram (1 revision)
- ACCN3 (1 revision)
- 5-alpha-reductase deficiency future or investigational therapies (1 revision)
- ALDH5A1 (gene) (1 revision)
- ALIVE (1 revision)
- ACCN1 (1 revision)
- ALOXE3 (1 revision)
- ALLHAT trial (1 revision)
- ALPK1 (1 revision)
- ACTL7A (1 revision)
- ALS2CR8 (1 revision)
- ACTN1 (1 revision)
- ACTN3 (gene) (1 revision)
- ACER3 (1 revision)
- ACTR3 (1 revision)
- ACTR2 (1 revision)
- 5-alpha-reductase deficiency primary prevention (1 revision)
- AM-855 (1 revision)
- ACTR3B (1 revision)
- 5-alpha-reductase deficiency secondary prevention (1 revision)
- 5-alpha-reductase deficiency surgery (1 revision)
- AM-905 (1 revision)
- AM-906 (1 revision)
- 5-bromouracil (1 revision)
- 5-hydroxytryptophan (1 revision)
- AMOT (1 revision)
- AM251 (1 revision)
- 5150 (Involuntary psychiatric hold) (1 revision)
- 5q- syndrome (1 revision)
- AMBN (1 revision)
- AMG-1 (1 revision)
- ACVR1C (1 revision)
- 6-Pyruvoyltetrahydropterin synthase deficiency (1 revision)
- AMG-3 (1 revision)
- AMBP (1 revision)
- AMG-41 (1 revision)
- 60S ribosomal protein L10 (1 revision)
- 60S ribosomal protein L10-like (1 revision)
- AMIGO (1 revision)
- 60S ribosomal protein L11 (1 revision)
- 60S ribosomal protein L12 (1 revision)
- 60S ribosomal protein L13 (1 revision)
- AMPA receptor (1 revision)
- 60S ribosomal protein L14 (1 revision)
- 60S ribosomal protein L15 (1 revision)
- 60S ribosomal protein L17 (1 revision)
- 60S ribosomal protein L18 (1 revision)
- 60S ribosomal protein L18a (1 revision)
- 60S ribosomal protein L19 (1 revision)
- 60S ribosomal protein L21 (1 revision)
- ANKFY1 (1 revision)
- 60S ribosomal protein L23 (1 revision)
- 60S ribosomal protein L23a (1 revision)
- 60S ribosomal protein L24 (1 revision)
- 60S ribosomal protein L26 (1 revision)